Generic Medicines Stores under Ministry of Health and Family Welfare

ad
Pradhan Mantri Bhartiya Janaushadhi Kendras-IndianBureacracy
Pradhan Mantri Bhartiya Janaushadhi Kendras-IndianBureacracy

The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey has informed that Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), a total of 5440 dedicated retail outlets selling affordable generic medicines are functional in the country as on 15.07.2019. State-wise breakup is given below:

State wise Janaushadhi Kendras  as on 15.07.2019
Sl. No. Name of the State Number of Janaushadhi Kendras
1 Andaman & Nicobar 2
2 Andhra Pradesh 181
3 Arunachal Pradesh 24
4 Assam 79
5 Bihar 155
6 Chandigarh 5
7 Chhattisgarh 206
8 Dadar & Nagar Haveli 14
9 Daman & Diu 4
10 Delhi 96
11 Goa 8
12 Gujarat 494
13 Haryana 160
14 Himachal Pradesh 57
15 Jammu and Kashmir 56
16 Jharkhand 54
17 Karnataka 524
18 Kerala 465
19 Lakshadweep 0
20 Madhya Pradesh 145
21 Maharashtra 358
22 Manipur 35
23 Meghalaya 1
24 Mizoram 19
25 Nagaland 15
26 Odisha 174
27 Puducherry 14
28 Punjab 164
29 Rajasthan 127
30 Sikkim 2
31 Tamil Nadu 539
32 Telangana 117
33 Tripura 24
34 Uttar Pradesh 840
35 Uttarakhand 176
36 West Bengal 106
Total 5440

 

There is no definition of generic or branded medicines under the Drugs & Cosmetics Act, 1940 and Rules, 1945 made thereunder. However, generic medicines are generally those which contain same amount of same active ingredient(s) in same dosage form and are intended to be administered by the same route of administration as that of branded medicine. Further, drugs manufactured in the country, irrespective of whether they are generic or branded, are required to comply with the same standards as prescribed in the Drugs and Cosmetics Act, 1940 and Rules, 1945 made thereunder for their quality. As such they are expected to have similar effects.

The price of an unbranded generic version of a medicine is generally lower than the price of a corresponding branded medicine because in case of generic version, the pharmaceutical company does not have to spend money on promotion of its brand. The sale of a generic version is incentivized by a pharmaceutical company by keeping a high trade margin for wholesalers and retailers.

Medical Council of India (MCI) has notified an amendment in Clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 vide notification dated 21.09.2016, which stipulates that “Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs”. MCI has further issued a circular on 21.04.2017 vide which all the Registered Medical Practitioners under the Indian Medical Council (IMC) Act have been directed to comply with the aforesaid provisions.

Be the first to comment

Leave a Reply